In Brief Bhramar Mukherjee, Christopher Friese named associate directors at Rogel Cancer Center January 10, 2020Vol.46 No.02
In Brief Christopher Ballas appointed SVP at Innovative Cellular Therapeutics January 10, 2020Vol.46 No.02
NCI advisors approve seven concepts at joint NCAB/BSA meeting January 10, 2020Vol.46 No.02By Alexandria Carolan
Annals corrects NutriRECS red, processed meat papers to reflect industry-related funding from Texas A&M AgriLife January 10, 2020Vol.46 No.02By Matthew Bin Han Ong
Drugs & Targets FDA approves Lynparza as first-line maintenance treatment of germline BRCA-mutated metastatic pancreatic cancer January 03, 2020Vol.46 No.01
Drugs & Targets FDA approves Xtandi for metastatic castration-sensitive prostate indication January 03, 2020Vol.46 No.01
Drugs & Targets FDA approves treatment for patients with HER2-positive breast cancer who have progressed on available therapies January 03, 2020Vol.46 No.01
Drugs & Targets FDA grants accelerated approval to enfortumab vedotin-ejfv for metastatic urothelial cancer January 03, 2020Vol.46 No.01
Drugs & Targets FDA grants Avatrombopag Orphan Drug Designation for chemotherapy-induced thrombocytopenia January 03, 2020Vol.46 No.01
